Analytical Data
-
Gene name
SPON2
- Application
-
Alternative Names
SPON2；DIL1；Spondin-2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BUD6
-
Expression Region
27-331aa
-
AA Sequence
QPLG GESICSARAL AKYSITFTGK WSQTAFPKQY PLFRPPAQWS SLLGAAHSSD YSMWRKNQYV SNGLRDFAER GEAWALMKEI EAAGEALQSV HEVFSAPAVP SGTGQTSAEL EVQRRHSLVS FVVRIVPSPD WFVGVDSLDL CDGDRWREQA ALDLYPYDAG TDSGFTFSSP NFATIPQDTV TEITSSSPSH PANSFYYPRL KALPPIARVT LVRLRQSPRA FIPPAPVLPS RDNEIVDSAS VPETPLDCEV SLWSSWGLCG GHCGRLGTKS RTRYVRVQPA NNGSPCPELE EEAECVPDNC V
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SPON2, or spondin 2, is a member of the thrombospondin family of proteins associated with various physiological and pathological processes, particularly in the nervous system. Its study has gained prominence due to its roles in cell adhesion, axon guidance, and neuroinflammation. In the context of neurological disorders, SPON2 has been implicated in modulating neuronal growth and repair mechanisms, making it a potential biomarker or therapeutic target for conditions such as multiple sclerosis and spinal cord injury. Recent research has focused on the recombinant expression of SPON2 to elucidate its function in cellular pathways and to explore its therapeutic potential. By producing SPON2 as a recombinant protein, scientists aim to investigate its structure-function relationship, interactions with other proteins, and its influence on neuronal cells. Understanding the mechanisms by which SPON2 operates could provide insights into its role in neurodevelopment and degeneration, highlighting its importance in both fundamental neuroscience and potential clinical applications.
